In the literature: April 2019

von Bruxiola, Gema, Cejalvo, Juan-Miguel, Gambardella, Valentina, Cervantes, Andrés
Veröffentlicht in ESMO Open (2019)

In the literature: December 2019

von Gambardella, Valentina, Insa, Amelia, Cejalvo, Juan-Miguel, Cervantes, Andrés
Veröffentlicht in ESMO Open (2020)

In the literature: February 2020

von Roda, Desamparados, Gambardella, Valentina, Cejalvo, Juan-Miguel, Cervantes, Andrés
Veröffentlicht in ESMO Open (2020)

In the literature: June 2020

von Roda, Desamparados, Gambardella, Valentina, Cejalvo, Juan-Miguel, Cervantes, Andrés
Veröffentlicht in ESMO Open (2020)

In the literature: August 2020

von Gambardella, Valentina, Cejalvo, Juan-Miguel, Tarazona, Noelia, Cervantes, Andrés
Veröffentlicht in ESMO Open (2020)

In the literature: August 2018

von Gambardella, Valentina, Bruixola, Gema, Papaccio, Federica, Cejalvo, Juan-Miguel, Cervantes, Andrés
Veröffentlicht in ESMO Open (2019)

In the literature: June 2019

von Lamarca, Angela, Gambardella, Valentina, Cejalvo, Juan-Miguel, Fleitas-Kanonnikoff, Tania, Cervantes, Andrés
Veröffentlicht in ESMO Open (2019)

Primary paraesophageal Ewing’s sarcoma: an uncommon case report and literature review

von Tarazona, Noelia, Navarro, Lara, Cejalvo, Juan Miguel, Gambardella, Valentina, Pérez-Fidalgo, J Alejandro, Sempere, Alejo, Navarro, Samuel, Cervantes, Andrés
Veröffentlicht in Onco Targets Ther (2015)

Personalized Medicine: Recent Progress in Cancer Therapy

von Gambardella, Valentina, Tarazona, Noelia, Cejalvo, Juan Miguel, Lombardi, Pasquale, Huerta, Marisol, Roselló, Susana, Fleitas, Tania, Roda, Desamparados, Cervantes, Andres
Veröffentlicht in Cancers (Basel) (2020)

miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker

von Oltra, Sara S, Peña-Chilet, Maria, Martinez, Maria T, Tormo, Eduardo, Cejalvo, Juan Miguel, Climent, Joan, Eroles, Pilar, Lluch, Ana, Ribas, Gloria
Veröffentlicht in Breast Cancer (Auckl) (2020)

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer

von Collins, Denis, Jacob, Wolfgang, Cejalvo, Juan Miguel, Ceppi, Maurizio, James, Ian, Hasmann, Max, Crown, John, Cervantes, Andrés, Weisser, Martin, Bossenmaier, Birgit
Veröffentlicht in PLoS One (2017)

Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology

von Ibarrola-Villava, Maider, Fleitas, Tania, Llorca-Cardeñosa, Marta J., Mongort, Cristina, Alonso, Elisa, Navarro, Samuel, Burgues, Octavio, Vivancos, Ana, Cejalvo, Juan Miguel, Perez-Fidalgo, José Alejandro, Roselló, Susana, Ribas, Gloria, Cervantes, Andrés
Veröffentlicht in Oncotarget (2016)

Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer

von Garrido-Cano, Iris, Constâncio, Vera, Adam-Artigues, Anna, Lameirinhas, Ana, Simón, Soraya, Ortega, Belen, Martínez, María Teresa, Hernando, Cristina, Bermejo, Begoña, Lluch, Ana, Lopes, Paula, Henrique, Rui, Jerónimo, Carmen, Cejalvo, Juan Miguel, Eroles, Pilar
Veröffentlicht in Int J Mol Sci (2020)

HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women

von Oltra, Sara S., Cejalvo, Juan Miguel, Tormo, Eduardo, Albanell, Marta, Ferrer, Ana, Nacher, Marta, Bermejo, Begoña, Hernando, Cristina, Chirivella, Isabel, Alonso, Elisa, Burgués, Octavio, Peña-Chilet, Maria, Eroles, Pilar, Lluch, Ana, Ribas, Gloria, Martinez, María Teresa
Veröffentlicht in Cancers (Basel) (2020)

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

von Pattanayak, Birlipta, Garrido-Cano, Iris, Adam-Artigues, Anna, Tormo, Eduardo, Pineda, Begoña, Cabello, Paula, Alonso, Elisa, Bermejo, Begoña, Hernando, Cristina, Martínez, María Teresa, Rovira, Ana, Albanell, Joan, Rojo, Federico, Burgués, Octavio, Cejalvo, Juan Miguel, Lluch, Ana, Eroles, Pilar
Veröffentlicht in Front Oncol (2020)

Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer

von Adam-Artigues, Anna, Garrido-Cano, Iris, Carbonell-Asins, Juan Antonio, Lameirinhas, Ana, Simón, Soraya, Ortega-Morillo, Belén, Martínez, María Teresa, Hernando, Cristina, Constâncio, Vera, Burgues, Octavio, Bermejo, Begoña, Henrique, Rui, Lluch, Ana, Jerónimo, Carmen, Eroles, Pilar, Cejalvo, Juan Miguel
Veröffentlicht in Cancers (Basel) (2021)

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small...

von Cejalvo, Juan-Miguel, Jacob, Wolfgang, Fleitas Kanonnikoff, Tania, Felip, Enriqueta, Navarro Mendivil, Alejandro, Martinez Garcia, Maria, Taus Garcia, Alvaro, Leighl, Natasha, Lassen, Ulrik, Mau-Soerensen, Morten, Adessi, Celine, Michielin, Francesca, James, Ian, Ceppi, Maurizio, Hasmann, Max, Weisser, Martin, Cervantes, Andrés
Veröffentlicht in ESMO Open (2019)

A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer

von Pascual, Tomás, Martin, Miguel, Fernández-Martínez, Aranzazu, Paré, Laia, Alba, Emilio, Rodríguez-Lescure, Álvaro, Perrone, Giuseppe, Cortés, Javier, Morales, Serafín, Lluch, Ana, Urruticoechea, Ander, González-Farré, Blanca, Galván, Patricia, Jares, Pedro, Rodriguez, Adela, Chic, Nuria, Righi, Daniela, Cejalvo, Juan Miguel, Tonini, Giuseppe, Adamo, Barbara, Vidal, Maria, Villagrasa, Patricia, Muñoz, Montserrat, Prat, Aleix
Veröffentlicht in Front Oncol (2019)

The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver

von Hruschka, Natascha, Kalisz, Mark, Subijana, Maria, Graña-Castro, Osvaldo, Del Cano-Ochoa, Francisco, Brunet, Laia Paré, Chernukhin, Igor, Sagrera, Ana, De Reynies, Aurelien, Kloesch, Bernhard, Chin, Suet-Feung, Burgués, Octavio, Andreu, David, Bermejo, Begoña, Cejalvo, Juan Miguel, Sutton, Joe, Caldas, Carlos, Ramón-Maiques, Santiago, Carroll, Jason S., Prat, Aleix, Real, Francisco X., Martinelli, Paola
Veröffentlicht in Oncogene (2020)

Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-...

von Schneeweiss, Andreas, Park-Simon, Tjoung-Won, Albanell, Joan, Lassen, Ulrik, Cortés, Javier, Dieras, Veronique, May, Marcus, Schindler, Christoph, Marmé, Frederik, Cejalvo, Juan Miguel, Martinez-Garcia, Maria, Gonzalez, Iria, Lopez-Martin, Jose, Welt, Anja, Levy, Christelle, Joly, Florence, Michielin, Francesca, Jacob, Wolfgang, Adessi, Céline, Moisan, Annie, Meneses-Lorente, Georgina, Racek, Tomas, James, Ian, Ceppi, Maurizio, Hasmann, Max, Weisser, Martin, Cervantes, Andrés
Veröffentlicht in Invest New Drugs (2018)